Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industrial Farmaceutica Cantabria SA
Original Assignee
Industrial Farmaceutica Cantabria SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industrial Farmaceutica Cantabria SAfiledCriticalIndustrial Farmaceutica Cantabria SA
Priority to ES0303658ApriorityCriticalpatent/ES303658A1/en
Publication of ES303658A1publicationCriticalpatent/ES303658A1/en
Process for obtaining a new organic compound characterized by mixing equimolar amounts of prednisolone, camphorsulfonic acid anhydride which is dissolved in appropriate amounts of pyridine by stirring. (Machine-translation by Google Translate, not legally binding)
ES0303658A1964-09-011964-09-01Procedure for obtaining prednisolone canfosulfonate. (Machine-translation by Google Translate, not legally binding)
ExpiredES303658A1
(en)
Procedure for the obtaining of 1-p-chlorobencil-2- (1-pirrolidil-methyl) - benzymidazole (Machine-translation by Google Translate, not legally binding)
Procedure for the separation of a salt 4: 4'-bipiridilio of a mix or solution that contains it. (Machine-translation by Google Translate, not legally binding)